Tablets & Capsules

TC0919

Issue link: https://www.e-digitaleditions.com/i/1163217

Contents of this Issue

Navigation

Page 41 of 51

40 September 2019 Tablets & Capsules References 1. "SUPAC: Manufacturing Equipment Addendum Guidance for Industry." December 2014. Available at: https://www.fda.gov/regulatory-information/search- f d a - g u i d a n c e - d o c u m e n t s / s u p a c - m a n u f a c t u r i n g - equipment-addendum. 2. "SUPAC-IR: Immediate-Release Solid Oral Dosage Forms: Scale-Up and Post-Approval Changes: Chemistry, Manufacturing and Controls, In Vitro Dissolution Testing, and In Vivo Bioequivalence Documentation." November 1995. Available at: https://www.fda.gov/regulatory-inform ation/search-fda-guidance-documents/supac-ir-immediate- release-solid-oral-dosage-forms-scale-and-post-approval- changes-chemistry. 3. "Q4B Annex 6: Uniformity of Dosage Units General Chapter." June 2014. Available at: https://www.fda.gov/ regulatory-information/search-fda-guidance-documents/ q4b-annex-6-uniformity-dosage-units-general-chapter. Fred A. Rowley is president and chief guest lecturer at Solid Dosage Training (925 352 5724, bostonmarathonironman@ yahoo.com). Rowley is also a member of Tablets & Capsules' editorial advisory board. equivalent yet produce very different results when using the same processing parameters. This problem also occurs in bin, cube, and octagonal blenders, where the blender shapes differ greatly, yet the blenders are expected to produce equivalent lubrication. And the differences don't stop at the vessel shape; there is also no universal approach to baffle configuration or placement, as shown by the examples in Figure 3. Conclusion If R&D was able to obtain both the target and maxi- mum tablet hardness values and establish a specification but production cannot achieve those values, something has changed, and that change may have been to the blending process. Causes of soft tablets include using a different blender fill volume (occupancy), a key raw material with a different bulk density, a different blender type (though it may be SUPAC-equivalent), a different lubricant morphology, or all of the above (see Table 2). These blending-related process differences can have real impacts on tablet hardness and can be damaging to prod- uct quality if not addressed. T&C

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0919